Trial Profile
Evaluation of treatment outcomes and analysis of potential predictive factors of ramucirumab and paclitaxel treatment in patients with advanced gastric cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Apr 2017
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Ramucirumab (Primary)
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- 04 Apr 2017 New trial record